BACKGROUND: Juvenile myoclonic epilepsy (JME) is an idiopathic generalized epilepsy (IGE) with complex inheritance. Previous studies have suggested maternal inheritance and female excess in IGEs but have not been specific for JME. We investigated evidence for maternal inheritance, female excess and patterns of familial seizure risk in a well-characterized sample of JME families. METHODS: We ascertained 89 families through a JME proband and 50 families through a non-JME IGE proband. JME families were divided into those with and without evidence of linkage to the EJM1 susceptibility locus on chromosome 6. We analyzed transmission in 43 multigenerational families, calculated the adjusted sex ratio for JME, and looked for evidence of seizure specific risk in 806 family members. RESULTS: We found evidence for preferential maternal transmission in both EJM1-linked and unlinked families (2.7:1), evidence even more marked when potential selection factors were excluded. The adjusted female: male risk ratio was very high in JME (RR=12.5; 95% CI: 1.9-83.7). Absence seizures in JME probands increased the overall risk of seizures in first degree relatives (15.8% vs. 7.0%, P=0.011), as well as first-degree relatives' specific risk of absence seizures (6% vs. 1.6%, P=0.01), but not myoclonic seizures. CONCLUSIONS: We have confirmed the finding of maternal inheritance in JME, which is not restricted to JME families linked to the EJM1 locus. The striking female excess in JME may relate to anatomical and/or endocrine sexual dimorphism in the brain. Evidence for independent inheritance of absence and myoclonic seizures in JME families reinforces a model in which combinations of loci confer susceptibility to the component seizure types of IGE.
BACKGROUND:Juvenile myoclonic epilepsy (JME) is an idiopathic generalized epilepsy (IGE) with complex inheritance. Previous studies have suggested maternal inheritance and female excess in IGEs but have not been specific for JME. We investigated evidence for maternal inheritance, female excess and patterns of familial seizure risk in a well-characterized sample of JME families. METHODS: We ascertained 89 families through a JME proband and 50 families through a non-JME IGE proband. JME families were divided into those with and without evidence of linkage to the EJM1 susceptibility locus on chromosome 6. We analyzed transmission in 43 multigenerational families, calculated the adjusted sex ratio for JME, and looked for evidence of seizure specific risk in 806 family members. RESULTS: We found evidence for preferential maternal transmission in both EJM1-linked and unlinked families (2.7:1), evidence even more marked when potential selection factors were excluded. The adjusted female: male risk ratio was very high in JME (RR=12.5; 95% CI: 1.9-83.7). Absence seizures in JME probands increased the overall risk of seizures in first degree relatives (15.8% vs. 7.0%, P=0.011), as well as first-degree relatives' specific risk of absence seizures (6% vs. 1.6%, P=0.01), but not myoclonic seizures. CONCLUSIONS: We have confirmed the finding of maternal inheritance in JME, which is not restricted to JME families linked to the EJM1 locus. The striking female excess in JME may relate to anatomical and/or endocrine sexual dimorphism in the brain. Evidence for independent inheritance of absence and myoclonic seizures in JME families reinforces a model in which combinations of loci confer susceptibility to the component seizure types of IGE.
Authors: F V Elmslie; M Rees; M P Williamson; M Kerr; M J Kjeldsen; K A Pang; A Sundqvist; M L Friis; D Chadwick; A Richens; A Covanis; M Santos; A Arzimanoglou; C P Panayiotopoulos; D Curtis; W P Whitehouse; R M Gardiner Journal: Hum Mol Genet Date: 1997-08 Impact factor: 6.150
Authors: T Sander; B Bockenkamp; T Hildmann; R Blasczyk; R Kretz; T F Wienker; A Volz; B Schmitz; G Beck-Mannagetta; O Riess; J T Epplen; D Janz; A Ziegler Journal: Neurology Date: 1997-09 Impact factor: 9.910
Authors: M Durner; G Zhou; D Fu; P Abreu; S Shinnar; S R Resor; S L Moshe; D Rosenbaum; J Cohen; C Harden; H Kang; S Wallace; D Luciano; K Ballaban-Gil; I Klotz; E Dicker; D A Greenberg Journal: Am J Hum Genet Date: 1999-05 Impact factor: 11.025
Authors: D A Greenberg; M Durner; M Keddache; S Shinnar; S R Resor; S L Moshe; D Rosenbaum; J Cohen; C Harden; H Kang; S Wallace; D Luciano; K Ballaban-Gil; L Tomasini; G Zhou; I Klotz; E Dicker Journal: Am J Hum Genet Date: 2000-02 Impact factor: 11.025
Authors: David A Greenberg; Eftihia Cayanis; Lisa Strug; Sudhir Marathe; Martina Durner; Deb K Pal; Gabriele B Alvin; Irene Klotz; Elisa Dicker; Shlomo Shinnar; Edward B Bromfield; Stanley Resor; Jeffrey Cohen; Solomon L Moshe; Cynthia Harden; Harriet Kang Journal: Am J Hum Genet Date: 2004-11-05 Impact factor: 11.025
Authors: A W Liu; A V Delgado-Escueta; J M Serratosa; M E Alonso; M T Medina; M N Gee; S Cordova; H Z Zhao; J M Spellman; J R Peek Journal: Am J Hum Genet Date: 1995-08 Impact factor: 11.025
Authors: Isabell Brikell; Laura Ghirardi; Brian M D'Onofrio; David W Dunn; Catarina Almqvist; Søren Dalsgaard; Ralf Kuja-Halkola; Henrik Larsson Journal: Biol Psychiatry Date: 2017-08-12 Impact factor: 13.382
Authors: David A Greenberg; Maria Cristina Monti; Bjarke Feenstra; Junying Zhang; Susan E Hodge Journal: Ann Hum Genet Date: 2010-03-31 Impact factor: 1.670
Authors: Ricky S Joshi; Paras Garg; Noah Zaitlen; Tuuli Lappalainen; Corey T Watson; Nidha Azam; Daniel Ho; Xin Li; Stylianos E Antonarakis; Han G Brunner; Karin Buiting; Sau Wai Cheung; Bradford Coffee; Thomas Eggermann; David Francis; Joep P Geraedts; Giorgio Gimelli; Samuel G Jacobson; Cedric Le Caignec; Nicole de Leeuw; Thomas Liehr; Deborah J Mackay; Stephen B Montgomery; Alistair T Pagnamenta; Peter Papenhausen; David O Robinson; Claudia Ruivenkamp; Charles Schwartz; Bernhard Steiner; David A Stevenson; Urvashi Surti; Thomas Wassink; Andrew J Sharp Journal: Am J Hum Genet Date: 2016-08-25 Impact factor: 11.025